A team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center has earned a five-year, $14.54 million award from the National Cancer Institute (NCI) to expand a promising immunotherapy platform.
Today, Univera Healthcare made a $110,000 grant to Roswell Park Comprehensive Cancer Center in support of colon cancer screening and education. Art Wingerter, President of Univera Healthcare, announced the gift at Roswell Park along with Candace S. Johnson, PhD, Roswell Park President and CEO; Mary Reid, MSPH, PhD, Director of Cancer Screening and Survivorship; and Joanne Haefner, Chief Executive Office of Neighborhood Health Center.
Roswell Park Comprehensive Cancer Center researchers conducting the first large-scale analysis of a gene regulatory mechanism that, when altered, can lead to cancerous growth have found compelling evidence of the role it plays in the development of pancreatic cancer. They share these new findings in an article in the journal Genome Research.
A team of researchers from Roswell Park Comprehensive Cancer Center and the Environmental Health Laboratory in the CDC’s National Center for Environmental Health have published new evidence expanding that inhalation of vitamin E acetate is strongly linked to e-cigarette, or vaping, product use-associated lung injury (EVALI).
A Roswell Park Comprehensive Cancer Center research team has identified a novel combination therapy that demonstrates a new approach to treating prostate cancer, reporting their findings in the journal Nature Communications. This new therapeutic strategy is the first to target metabolic processes uniquely important to prostate cancer — specifically, two enzymes in the connected polyamine catabolic pathway and the methionine salvage pathway.